Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS Gains 8%; BSE HEALTHCARE Index Down 0.4%
Wed, 27 Nov 13:40

NEULAND LABS Gains 8%; BSE HEALTHCARE Index Down 0.4%Image source: phive2015/www.istockphoto.com

NEULAND LABS share price has zoomed 8% and is presently trading at Rs 15,957.9.

Meanwhile, the BSE HEALTHCARE index is at 42,974.8 (down 0.4%).

Among the top gainers in the BSE HEALTHCARE index today are ASTER DM HEALTHCARE (up 7.0%) and MAX HEALTHCARE INSTITUTE (up 2.1%).

GRANULES INDIA (down 3.4%) and Procter & Gamble Health (down 2.9%) are among the top losers today.

Over the last one year, NEULAND LABS has moved up from Rs 5,217.6 to Rs 15,957.9, registering a gain of Rs 10,740.3 (up 205.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 29,654.9 to 42,974.8, registering a gain of 44.9% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 164.5%), Glenmark Pharma (up 96.7%) and SUVEN PHARMACEUTICALS (up 94.4%).

End of Year Sale: Grab our small cap recommendation service at 60% off!

What About the Benchmark Indices?

The BSE Sensex is at 80,380.1 (up 0.5%).

The top gainers among the BSE Sensex today are MUNDRA PORT & SEZ (up 6.9%) and NTPC (up 2.4%). The most traded stocks in the BSE Sensex are NTPC and Tata Steel.

In the meantime, NSE Nifty is at 24,301.1 (up 0.4%). Adani Enterprises and MUNDRA PORT & SEZ are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,174.2 to 80,380.1, registering a gain of 14,205.9 points (up 21.5%).

NEULAND LABS Financial Update...

NEULAND LABS net profit fell 63.2% YoY to Rs 328 million for the quarter ended September 2024, compared to a profit of Rs 892 million a year ago. Net sales declined 25.6% to Rs 3,108 million during the period as against Rs 4,177 million in July-September 2023.

For the year ended March 2024, NEULAND LABS reported 83.5% increase in net profit to Rs 3,001 million compared to net profit of Rs 1,635 million during FY23. Revenue of the company grew 30.8% to Rs 15,586 million during FY24.

The current Price to earnings ratio of NEULAND LABS, based on rolling 12 month earnings, stands at 73.2.


Equitymaster requests your view! Post a comment on "NEULAND LABS Gains 8%; BSE HEALTHCARE Index Down 0.4%". Click here!